HOUSE BILL 2164

How Centralized Fulfillment is Making Pharmacy More Efficient

FDA approval was granted on September 13, 2024.

FDA Approves Acoramidis for ATTR-CM

Tom Utech, PharmD, CEO of iA, joined Drug Topics to discuss his company’s centralized pharmacy fulfillment solutions.

FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?

This approval marks the availability of the first near-complete stabilizer of transthyretin.

October 31st 2024

Disconnect Between Adolescent, Caregiver Pain and Depression Symptoms in Rheumatic Diseases | ACR Convergence

Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.

H5N1 Bird Flu: A Slowly Looming Public Health Threat

PROMIS scores demonstrated the disparities between reported pain and mental health outcomes.

Drug Review: Lebrikizumab-lbkz Demonstrates Improvement in Atopic Dermatitis

Public health and infectious disease experts offered their perspectives on the 2024 US bird flu outbreak and its potential of becoming a greater public health crisis.

Related Content

Allison Ketterer, PharmD Candidate

How Centralized Fulfillment is Making Pharmacy More Efficient

FDA approval was granted on September 13, 2024.

FDA Approves Acoramidis for ATTR-CM

Tom Utech, PharmD, CEO of iA, joined Drug Topics to discuss his company’s centralized pharmacy fulfillment solutions.

FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?

This approval marks the availability of the first near-complete stabilizer of transthyretin.

October 31st 2024

Disconnect Between Adolescent, Caregiver Pain and Depression Symptoms in Rheumatic Diseases | ACR Convergence

H5N1 Bird Flu: A Slowly Looming Public Health Threat

PROMIS scores demonstrated the disparities between reported pain and mental health outcomes.